Skip to main content

30-day mortality and readmission after hemorrhagic stroke among Medicare beneficiaries in Joint Commission primary stroke center-certified and noncertified hospitals.

Publication ,  Journal Article
Lichtman, JH; Jones, SB; Leifheit-Limson, EC; Wang, Y; Goldstein, LB
Published in: Stroke
December 2011

BACKGROUND AND PURPOSE: Ischemic stroke patients treated at Joint Commission Primary Stroke Center (JC-PSC)-certified hospitals have better outcomes. Data reflecting the impact of JC-PSC status on outcomes after hemorrhagic stroke are limited. We determined whether 30-day mortality and readmission rates after hemorrhagic stroke differed for patients treated at JC-PSC-certified versus noncertified hospitals. METHODS: The study included all fee-for-service Medicare beneficiaries aged 65 years or older with a primary discharge diagnosis of subarachnoid hemorrhage (SAH) or intracerebral hemorrhage (ICH) in 2006. Covariate-adjusted logistic and Cox proportional hazards regression assessed the effect of care at a JC-PSC-certified hospital on 30-day mortality and readmission. RESULTS: There were 2305 SAH and 8708 ICH discharges from JC-PSC-certified hospitals and 3892 SAH and 22 564 ICH discharges from noncertified hospitals. Unadjusted in-hospital mortality (SAH: 27.5% versus 33.2%, P<0.0001; ICH: 27.9% versus 29.6%, P=0.003) and 30-day mortality (SAH: 35.1% versus 44.0%, P<0.0001; ICH: 39.8% versus 42.4%, P<0.0001) were lower in JC-PSC hospitals, but 30-day readmission rates were similar (SAH: 17.0% versus 17.0%, P=0.97; ICH: 16.0% versus 15.5%, P=0.29). Risk-adjusted 30-day mortality was 34% lower (odds ratio, 0.66; 95% confidence interval, 0.58-0.76) after SAH and 14% lower (odds ratio, 0.86; 95% confidence interval, 0.80-0.92) after ICH for patients discharged from JC-PSC-certified hospitals. There was no difference in 30-day risk-adjusted readmission rates for SAH or ICH based on JC-PSC status. CONCLUSIONS: Patients treated at JC-PSC-certified hospitals had lower risk-adjusted mortality rates for both SAH and ICH but similar 30-day readmission rates as compared with noncertified hospitals.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Stroke

DOI

EISSN

1524-4628

Publication Date

December 2011

Volume

42

Issue

12

Start / End Page

3387 / 3391

Location

United States

Related Subject Headings

  • United States
  • Stroke
  • Risk
  • Neurology & Neurosurgery
  • Medicare
  • Male
  • Intracranial Hemorrhages
  • Humans
  • Hospitals
  • Hospitalization
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lichtman, J. H., Jones, S. B., Leifheit-Limson, E. C., Wang, Y., & Goldstein, L. B. (2011). 30-day mortality and readmission after hemorrhagic stroke among Medicare beneficiaries in Joint Commission primary stroke center-certified and noncertified hospitals. Stroke, 42(12), 3387–3391. https://doi.org/10.1161/STROKEAHA.111.622613
Lichtman, Judith H., Sara B. Jones, Erica C. Leifheit-Limson, Yun Wang, and Larry B. Goldstein. “30-day mortality and readmission after hemorrhagic stroke among Medicare beneficiaries in Joint Commission primary stroke center-certified and noncertified hospitals.Stroke 42, no. 12 (December 2011): 3387–91. https://doi.org/10.1161/STROKEAHA.111.622613.
Lichtman, Judith H., et al. “30-day mortality and readmission after hemorrhagic stroke among Medicare beneficiaries in Joint Commission primary stroke center-certified and noncertified hospitals.Stroke, vol. 42, no. 12, Dec. 2011, pp. 3387–91. Pubmed, doi:10.1161/STROKEAHA.111.622613.

Published In

Stroke

DOI

EISSN

1524-4628

Publication Date

December 2011

Volume

42

Issue

12

Start / End Page

3387 / 3391

Location

United States

Related Subject Headings

  • United States
  • Stroke
  • Risk
  • Neurology & Neurosurgery
  • Medicare
  • Male
  • Intracranial Hemorrhages
  • Humans
  • Hospitals
  • Hospitalization